<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Glaxo&#8217;s Chris Viehbacher Is Resigning</title>
	<atom:link href="http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 19:30:53 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Plotnikoff</title>
		<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/#comment-466791</link>
		<dc:creator>Plotnikoff</dc:creator>
		<pubDate>Thu, 18 Feb 2010 14:47:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15333#comment-466791</guid>
		<description>TNI Pharma seeking merger with aggressive biotech company IN USA or Europe</description>
		<content:encoded><![CDATA[<p>TNI Pharma seeking merger with aggressive biotech company IN USA or Europe</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Plotnikoff</title>
		<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/#comment-466790</link>
		<dc:creator>Plotnikoff</dc:creator>
		<pubDate>Thu, 18 Feb 2010 14:46:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15333#comment-466790</guid>
		<description>TNI Pharmaceuticals, Inc.   China and India
breakthrough pancreatic cancer therapy  remissions   extended longevity average 12 months versus 5 months for Gemcitabine
New Address 25 Harbor Road Ocean City NJ 08226</description>
		<content:encoded><![CDATA[<p>TNI Pharmaceuticals, Inc.   China and India<br />
breakthrough pancreatic cancer therapy  remissions   extended longevity average 12 months versus 5 months for Gemcitabine<br />
New Address 25 Harbor Road Ocean City NJ 08226</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: plotnikoff</title>
		<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/#comment-386016</link>
		<dc:creator>plotnikoff</dc:creator>
		<pubDate>Thu, 01 Jan 2009 13:05:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15333#comment-386016</guid>
		<description>Seeking corporate partner for world wide
clinical development and marketing our new
therapy for pancreatic cancer</description>
		<content:encoded><![CDATA[<p>Seeking corporate partner for world wide<br />
clinical development and marketing our new<br />
therapy for pancreatic cancer</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: plotnikoff</title>
		<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/#comment-373897</link>
		<dc:creator>plotnikoff</dc:creator>
		<pubDate>Wed, 17 Sep 2008 14:51:45 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15333#comment-373897</guid>
		<description>join us in TNI Pharmaceuticals</description>
		<content:encoded><![CDATA[<p>join us in TNI Pharmaceuticals</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: plotnikoff</title>
		<link>http://www.pharmalot.com/2008/09/glaxos-chris-viehbacher-is-resigning/#comment-373895</link>
		<dc:creator>plotnikoff</dc:creator>
		<pubDate>Wed, 17 Sep 2008 14:50:45 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15333#comment-373895</guid>
		<description>To Chris Viehbacher
We would like to invite you to join us on the board of directors of our
biotech company TNI Pharmaceuticals
breaktrough pancreatic cancer therapy
and 
new development in AIDS vaccine
contact Chairman Nick Plotnikoff</description>
		<content:encoded><![CDATA[<p>To Chris Viehbacher<br />
We would like to invite you to join us on the board of directors of our<br />
biotech company TNI Pharmaceuticals<br />
breaktrough pancreatic cancer therapy<br />
and<br />
new development in AIDS vaccine<br />
contact Chairman Nick Plotnikoff</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.151 seconds -->

